XML 50 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Assets and Liabilities Measured at Fair Value (Tables)
12 Months Ended
Dec. 31, 2017
Financial assets and liabilities subject to fair value measurements  
Summary of assets and liabilities subject to fair value measurements

        A summary of the fair value of the Company's recurring assets and liabilities aggregated by the level in the fair value hierarchy within which those measurements fall as of December 31, 2017 are identified in the following table (in thousands):

                                                                                                                                                                                    

 

 

Level 2

 

Total

 

Assets:

 

 

 

 

 

 

 

Commercial paper

 

$

79,803

 

$

79,803

 

Asset-back securities

 

 

30,287

 

 

30,287

 

Corporate debt securities

 

 

199,012

 

 

199,012

 

Money market funds

 

 

2,598

 

 

2,598

 

​  

​  

​  

​  

 

 

$

311,700

 

$

311,700

 

​  

​  

​  

​  

​  

​  

​  

​  

 

                                                                                                                                                                                    

 

 

Level 2

 

Level 3

 

Total

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

$

 

$

25,400

 

$

25,400

 

Deferred compensation plan liability

 

 

2,258

 

 

 

 

2,258

 

​  

​  

​  

​  

​  

​  

 

 

$

2,258

 

$

25,400

 

$

27,658

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

        A summary of the fair value of the Company's assets and liabilities aggregated by the level in the fair value hierarchy within which those measurements fall as of December 31, 2016 are identified in the following table (in thousands):

                                                                                                                                                                                    

 

 

Level 2

 

Total

 

Assets:

 

 

 

 

 

 

 

Commercial paper

 

$

68,390

 

$

68,390

 

Corporate debt securities

 

 

74,535

 

 

74,535

 

Money market funds

 

 

1,829

 

 

1,829

 

​  

​  

​  

​  

 

 

$

144,754

 

$

144,754

 

​  

​  

​  

​  

​  

​  

​  

​  

 

                                                                                                                                                                                    

 

 

Level 2

 

Level 3

 

Total

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

$

 

$

269,722

 

$

269,722

 

Derivative liability

 

 

265

 

 

 

 

265

 

Deferred compensation plan liability

 

 

1,479

 

 

 

 

1,479

 

​  

​  

​  

​  

​  

​  

 

 

$

1,744

 

$

269,722

 

$

271,466

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Schedule of changes in contingent consideration payable

        The following table shows the change in the balance of contingent consideration payable for the year ended December 31, 2017 and 2016, respectively (in thousands):

                                                                                                                                                                                    

 

 

Year ended December 31,

 

 

 

2017

 

2016

 

Balance, beginning of the period

 

$

269,722

 

$

274,077

 

Payment of contingent consideration in cash

 

 

(10,000

)

 

(5,000

)

Payment of contingent consideration in stock

 

 

 

 

(6,115

)

Unrealized change in fair value change during the period, included in Statement of Operations

 

 

(234,322

)

 

6,760

 

​  

​  

​  

​  

Balance, end of the period

 

$

25,400

 

$

269,722

 

​  

​  

​  

​  

​  

​  

​  

​  

 

Callidus  
Financial assets and liabilities subject to fair value measurements  
Schedule of significant unobservable inputs used in the valuation of the contingent consideration payable

                                                                                                                                                                                    

Contingent Consideration Liability

 

Fair value as of
December 31,
2017

 

Valuation Technique

 

Unobservable Input

 

Range

 

 

 

 

 

 

Discount rate

 

11.5%

Clinical and regulatory milestones

 

$25.0 million

 

Probability weighted discounted cash flow

 

Probability of achievement of milestones

 

71.0% - 100.0%

 

 

 

 

 

 

Projected year of payments

 

2018 - 2022